MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

By

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

"I find it particularly helpful in identifying repeated glucose lows at night and glucose highs after meals," University Diabetes & Endocrine Consultants’ Dr. David Huffman said in prepared remarks. "I am one doctor in a busy office, but the advances with iPro2 will make Professional CGM accessible to more patients who need it. I see that as better medicine."

Professional CGM is ideal for patients with Type I or Type II diabetes who have are persistently unaware of extreme highs and lows in their glucose levels, according to a published consensus from the American Assn. of Clinical Endocrinologists. The clinician-led process was also recommended for pregnant women and youth with Type I diabetes.

Proper glucose control may help patients avoid complications associated with diabetes, including blindness, kidney failure, amputation, impotence and heart disease, according to a press release.

"CGM adoption is on the rise," Medtronic VP and general manager for the continuous glucose monitoring business Greg Meehan said in prepared remarks. "We believe the combination of improved reimbursement for both clinicians and patients, increased clinical evidence as seen in the Medtronic STAR 3 and JDRF trials, as well as ongoing product advancements, are moving CGM devices toward the standard of care for diabetes management."

Regulatory Roundup

  • Medtronic wins FDA nod for AdaptiveStim neurostimulator
    Medtronic announced approval of its AdaptiveStim with RestoreSensor neurostimulation system, the first and only chronic pain treatment that harnesses motion sensor technology found in smart phones and computer gaming systems to provide effective pain relief and convenience by automatically adapting stimulation levels.
    Read more

  • IntriCon lands 510(k) for cardiac diagnostic monitor
    IntriCon Corporation (NSDQ: IIN), developer of miniature and micro-miniature body-worn devices, received 510(k) clearance for its Sirona Event and Holter Recorder, the company’s second-generation cardiac diagnostic monitoring device, allowing physicians to monitor patient cardiac events remotely .
    Read more

  • SonoSite gets green light for Edge ultrasound system
    SonoSite Inc. (NSDQ:SONO) received FDA 510(k) clearance for its fifth-generation Edge ultrasound system.
    Read more

  • Staar Surgical wins CE mark for intraocular lens
    Staar Surgical Co., which designs, develops, manufactures and markets implantable lenses for the eye, received CE Mark approval in the European Union for its nanoFLEX Toric Collamer Single Piece intraocular lens.
    Read more

  • Vascular Designs lands regulatory wins for sideways perfusion catheter
    The IsoFlow Infusion Catheter, from Vascular Designs Inc.,  received CE Mark approval for use in Europe and Canada.
    Read more

  • Neovasc touts CE Mark for angina therapy
    Neovasc Inc. (NYSE: NVC) received CE mark approval for its Reducer product, which was developed to treat refractory angina.
    Read more

  • BSD Medical lands humanitarian device exemption
    BSD Medical Corp. (NSDQ:BSDM) obtained humanitarian device exemption marketing approval for the BSD-2000 Hyperthermia System.
    Read more

  • Dendreon Corp. wins reimbursement approval for Provenge
    Dendreon Corp. (NSDQ:DNDN) today announced the Centers for Medicare & Medicaid Services updated their coverage policy to now cover the infusion costs associated with the administration of Provenge.
    Read more

  • Retina Implant AG plans second human clinical trial
    Retina Implant AG announced that its scientific advisory board is in full support of beginning the multi-center phase of the company’s second human clinical trial for subretinal implants for retinitis pigmentosa patients.
    Read more

  • IsoRay wins State of Wash. approval for GliaSite
    IsoRay Inc. (AMEX: ISR) received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer.
    Read more

  • Canon touts clearance for radiography detectors
    Canon U.S.A. Inc. announced that the Canon CXDI-80C Wireless Digital Radiography Detector, along with the CXDI-501 Series DR Detectors, received 510(k) clearance.
    Read more

  • CerMed wins CE Mark for CerMap
    CerMed International, an international women’s medical device company, announced that it received CE Mark approval for CerMap, its advanced Cervical Specimen Collection Device used in cervical cancer screening procedures.
    Read more

  • Translational Sciences wins FDA clearance for imaging software
    Translational Sciences Corporation received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
    Read more

  • Merz Aesthetics gets green light for wrinkle treatment
    Merz Aesthetics today announced that the FDA cleared the Belotero Balance device for the correction of moderate-to-severe facial wrinkles and folds.

    Read more

    • In case you missed it

    RSS From Medical Design & Outsourcing

    • Greenlight Guru to provide QMS to NIH diagnostics program
      NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]
    • MicroCare names CFO
      MicroCare (New Britain, Conn.) has announced the appointment of John Stardellis as the company’s new chief financial officer (CFO). Stardellis joins MicroCare with more than 20 years’ experience in a variety of finance, policy and operational leadership roles. Most recently, he served as CFO at i-Health, a division of DSM Nutritional Products. “John’s track record with… […]
    • Mayo Clinic helps launch two new companies for improved diagnostics
      Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. Get the full story… […]
    • Intertek gains FDA nod for premarket device testing
      Intertek has won accreditation under an FDA pilot program for testing laboratories, the company said this week. The accreditation authorizes Intertek’s 12 “medical centers of excellence” to perform premarket testing of devices for the U.S. market. The Accreditation Scheme for Conformity Assessment pilot program is a voluntary program developed to provide increased confidence in testing… […]
    • HHS shoots down ‘flawed’ plan to let some devices skip review
      The Biden administration has nixed what it described as a “flawed” Trump-era decision to exempt certain medical devices — including infusion pump controllers and fetal monitors — from regulatory review. HHS published the original notice in the Federal Register on Jan. 15, shortly before President Joe Biden was set to take office, without speaking with… […]
    • More than 50 medtech testing sites win FDA pilot accreditation
      The FDA announced today that more than 50 laboratory sites were chosen to participate in its program for streamlined regulatory reviews. In total, 53 sites made the FDA’s initial list for participation in its Accreditation Scheme for Conformity Assessment (ASCA) program, which will set out to support more streamlined regulatory reviews of medical device market… […]
    • Medline Industries up for sale?
      Medline Industries is looking for a buyer in a deal that could be worth $30 billion, according to a report in the Wall Street Journal. The Journal cites “people familiar with the matter” saying that Northfield, Ill.-based Medline has hired Goldman Sachs to manage the process. The people added that the company might alternatively seek… […]
    • Micro to add plant in Costa Rica
      Contract manufacturer Micro today announced plans to open a new plant in Costa Rica. The 32,000 ft² facility will significantly increase Micro’s cleanroom assembly capacity, according to the Somerset, N.J.-based company. It will be located in the Zona Franca Metro business park and is expected to open in late 2021 with operations beginning in 2022.… […]
    • Survey shows solid medical device industry performance despite pandemic
      By Stewart Eisenhart, Emergo Group Medical device and IVD manufacturers report healthy performance over the course of 2020, but also faced significant operational and regulatory challenges related to the coronavirus pandemic. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not… […]
    • Cardinal Health wins $58M federal PPE contract
      Cardinal Health (NYSE: CAH) today said it has won a $57.8 million contract from the U.S. Dept. of Health and Human Services to support the Strategic National Stockpile. The Dublin, Ohio-based company received the contract, which includes options that if exercised by the HHS could reach $91.6 million, to store and distribute 80,000 pallets of… […]
    • Qosina adds single-use bioprocessing devices
      Qosina this week launched its product line for the single-use bioprocess industry. The new product line includes tube-to-tube bard connectors, luer fittings, check valves, tubing pinch clamps, tubing, steam thru connectors and more. Get the full story on our sister site, Medical Tubing + Extrusion. The post Qosina adds single-use bioprocessing devices appeared first on […]

    Leave a Reply